GlassScriptPhysician profile
Katelyn Barnes
NPI 1003477092
$3,037.43
in general payments reported to CMS, 2019-2025
17 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,259 · 2022: $1,146 · 2023: $325 · 2024: $197 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,308.99 | 2021-2022 | |
| Abbott Laboratories | $434.46 | 2023-2025 | Proclaim, Eterna, Prodigy |
| Boston Scientific Corporation | $422.14 | 2021-2025 | Infinion 16, Linear, Infinion 16 |
| Arbor Pharmaceuticals, INC. | $181.59 | 2021-2022 | |
| Forte Bio-Pharma LLC | $82.03 | 2022 | |
| Medtronic, INC. | $81.39 | 2022 | |
| Amgen INC. | $77.03 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $74.10 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $69.84 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $69.16 | 2021 | |
| Nevro Corp. | $51.23 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $47.91 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $46.05 | 2021 | |
| Redhill Biopharma INC. | $34.17 | 2021-2022 | |
| Bioventus LLC | $25.34 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $17.85 | 2021 | |
| Argenx US, INC. | $14.15 | 2024 | Vyvgart Hytrulo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.